Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.
| Current Price | ₹6,027.50 |
|---|---|
| Market Cap | ₹10,005 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 30.6 |
| Return on Equity | 61.59% |
| 52-Week Range | ₹9,388.75 – ₹14,620.45 |
| Beta (1Y) | 0.16 |
| Dividend Yield | 1.49% |
1. Pharmaceuticals-100%
Procter & Gamble Health Ltd is trading at ₹6,027.50, with a market capitalisation of ₹10,005 Cr.
Procter & Gamble Health Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Procter & Gamble Health Ltd has a P/E of 30.6 and a return on equity of 61.59%.